Quantitative Dynamic Contrast-enhanced and Diffusion-weighted MRI for Differentiation Between Nasopharyngeal Carcinoma and Lymphoma at the Primary Site

Overview

Journal Dentomaxillofac Radiol

Publisher Oxford University Press

Date 2016 Feb 6

PMID 26846711

Citations 8

Authors

Xiao-Ping Yu

Jing Hou

Fei-Ping Li

Wang Xiang

Qiang Lu

Yin Hu

Hui Wang

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the value of quantitative dynamic contrast-enhanced MRI (QDCE-MRI) and diffusion-weighted MRI (DW-MRI) in differentiating nasopharyngeal carcinoma (NPC) from lymphoma.

Methods: We retrospectively analysed the data from 102 patients (82 with NPC and 20 with lymphoma) who underwent pre-treatment QDCE-MRI and DW-MRI on a 1.5-T MR unit. QDEC-MRI parameters [influx transfer constant (K(trans)), efflux rate constant (Kep), fractional volume of extravascular extracellular space (Ve) and fractional volume of plasma (fPV)] based on pharmacokinetic model and apparent diffusion coefficient (ADC) were compared between the two nasopharyngeal malignancies.

Results: The K(trans), Kep, Ve, fPV and ADC values (mean ± standard deviation) for NPC were 0.366 ± 0.155 min(-1), 1.353 ± 0.468 min(-1), 0.292 ± 0.117, 0.027 ± 0.024 and 0.981 ± 0.184 × 10(-3) mm(2) s(-1), respectively. The K(trans), Kep, Ve, fPV and ADC values (mean ± standard deviation) for lymphoma were 0.212 ± 0.059 min(-1), 1.073 ± 0.238 min(-1), 0.213 ± 0.104, 0.008 ± 0.007 and 0.760 ± 0.182 × 10(-3) mm(2) s(-1), respectively. Optimal cut-off values (area under the curve, sensitivity, specificity) for distinguishing the two tumours were as follows: K(trans) = 0.262 min(-1) (0.866, 80.49%, 85.00%), Kep = 1.401 min(-1) (0.681, 43.90%, 100.00%), Ve = 0.211 (0.784, 76.83%, 85.00%), fPV = 0.012 (0.779, 60.98%, 85.00%), ADC = 0.761 × 10(-3) mm(2) s(-1) (0.781, 93.90%, 55.00%).

Conclusions: QDCE-MRI together with DW-MRI is useful for differentiation between NPC and lymphoma.

Citing Articles

Value of multiparametric magnetic resonance imaging in distinguishing sinonasal lymphoma from sinonasal carcinoma: a case control study.

Liu C, Wang Y, Zhang D, Zhou J, Wu Y, Guo Y BMC Med Imaging. 2024; 24(1):181.

PMID: 39048981 PMC: 11267685. DOI: 10.1186/s12880-024-01366-6.

Synthetic MRI and diffusion-weighted imaging for differentiating nasopharyngeal lymphoma from nasopharyngeal carcinoma: combination with morphological features.

Zhang H, Hu L, Qin F, Chang J, Zhong Y, Dou W Br J Radiol. 2024; 97(1159):1278-1285.

PMID: 38733577 PMC: 11186575. DOI: 10.1093/bjr/tqae095.

Artificial intelligence for diagnosis and prognosis prediction of natural killer/T cell lymphoma using magnetic resonance imaging.

Zhang Y, Deng Y, Zou Q, Jing B, Cai P, Tian X Cell Rep Med. 2024; 5(5):101551.

PMID: 38697104 PMC: 11148767. DOI: 10.1016/j.xcrm.2024.101551.

Differentiating nasopharyngeal carcinoma from lymphoma in the head and neck region using the apparent diffusion coefficient (ADC) value: a systematic review and meta-analysis.

Tabnak P, HajiEsmailPoor Z Pol J Radiol. 2023; 88:e472-e482.

PMID: 38020498 PMC: 10660142. DOI: 10.5114/pjr.2023.132172.

Value of Apparent Diffusion Coefficient Histogram Analysis in the Differential Diagnosis of Nasopharyngeal Lymphoma and Nasopharyngeal Carcinoma Based on Readout-Segmented Diffusion-Weighted Imaging.

Song C, Cheng P, Cheng J, Zhang Y, Xie S Front Oncol. 2021; 11:632796.

PMID: 33777787 PMC: 7996088. DOI: 10.3389/fonc.2021.632796.

References

Ichikawa Y, Sumi M, Sasaki M, Sumi T, Nakamura T . Efficacy of diffusion-weighted imaging for the differentiation between lymphomas and carcinomas of the nasopharynx and oropharynx: correlations of apparent diffusion coefficients and histologic features. AJNR Am J Neuroradiol. 2011; 33(4):761-6. PMC: 8050466. DOI: 10.3174/ajnr.A2834. View

Kim J, Im G, Yang J, Choi D, Lee W, Lee J . Quantitative dynamic contrast-enhanced MRI for mouse models using automatic detection of the arterial input function. NMR Biomed. 2011; 25(4):674-84. DOI: 10.1002/nbm.1784. View

Sumi M, Nakamura T . Head and neck tumors: assessment of perfusion-related parameters and diffusion coefficients based on the intravoxel incoherent motion model. AJNR Am J Neuroradiol. 2012; 34(2):410-6. PMC: 7965088. DOI: 10.3174/ajnr.A3227. View

Huang B, Wong C, Whitcher B, Kwong D, Lai V, Chan Q . Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage. Eur Radiol. 2013; 23(6):1495-502. DOI: 10.1007/s00330-012-2740-7. View

Kato H, Kanematsu M, Kawaguchi S, Watanabe H, Mizuta K, Aoki M . Evaluation of imaging findings differentiating extranodal non-Hodgkin's lymphoma from squamous cell carcinoma in naso- and oropharynx. Clin Imaging. 2013; 37(4):657-63. DOI: 10.1016/j.clinimag.2012.11.007. View

Vos E, Litjens G, Kobus T, Hambrock T, Hulsbergen-van de Kaa C, Barentsz J . Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T. Eur Urol. 2013; 64(3):448-55. DOI: 10.1016/j.eururo.2013.05.045. View

Sumi M, Nakamura T . Head and neck tumours: combined MRI assessment based on IVIM and TIC analyses for the differentiation of tumors of different histological types. Eur Radiol. 2013; 24(1):223-31. DOI: 10.1007/s00330-013-3002-z. View

Yi B, Kang D, Yoon D, Jung Y, Kim K, Yim H . Is there any correlation between model-based perfusion parameters and model-free parameters of time-signal intensity curve on dynamic contrast enhanced MRI in breast cancer patients?. Eur Radiol. 2014; 24(5):1089-96. DOI: 10.1007/s00330-014-3100-6. View

Liu K, Xie P, Peng W, Zhou Z . Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions. J Comput Assist Tomogr. 2014; 38(5):681-6. DOI: 10.1097/RCT.0000000000000120. View

10.

Kitamoto E, Chikui T, Kawano S, Ohga M, Kobayashi K, Matsuo Y . The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors. Acad Radiol. 2014; 22(2):210-6. DOI: 10.1016/j.acra.2014.08.016. View

11.

Zheng D, Chen Y, Liu X, Chen Y, Xu L, Ren W . Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI. J Magn Reson Imaging. 2014; 41(6):1528-40. DOI: 10.1002/jmri.24723. View

12.

Wang J, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T . Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology. 2001; 220(3):621-30. DOI: 10.1148/radiol.2202010063. View

13.

Tofts P . Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997; 7(1):91-101. DOI: 10.1002/jmri.1880070113. View

14.

Sennino B, Raatschen H, Wendland M, Fu Y, You W, Shames D . Correlative dynamic contrast MRI and microscopic assessments of tumor vascularity in RIP-Tag2 transgenic mice. Magn Reson Med. 2009; 62(3):616-25. PMC: 5675714. DOI: 10.1002/mrm.22040. View

15.

Edge S, Compton C . The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17(6):1471-4. DOI: 10.1245/s10434-010-0985-4. View

16.

Ungersma S, Pacheco G, Ho C, Yee S, Ross J, van Bruggen N . Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magn Reson Med. 2010; 63(6):1637-47. DOI: 10.1002/mrm.22442. View

17.

Fong D, Bhatia K, Yeung D, King A . Diagnostic accuracy of diffusion-weighted MR imaging for nasopharyngeal carcinoma, head and neck lymphoma and squamous cell carcinoma at the primary site. Oral Oncol. 2010; 46(8):603-6. DOI: 10.1016/j.oraloncology.2010.05.004. View

18.

Yao W, Zhang H, Ding B, Fu T, Jia H, Pang L . Rectal cancer: 3D dynamic contrast-enhanced MRI; correlation with microvascular density and clinicopathological features. Radiol Med. 2011; 116(3):366-74. DOI: 10.1007/s11547-011-0628-2. View

19.

Lee F, King A, Ma B, Yeung D . Dynamic contrast enhancement magnetic resonance imaging (DCE-MRI) for differential diagnosis in head and neck cancers. Eur J Radiol. 2011; 81(4):784-8. DOI: 10.1016/j.ejrad.2011.01.089. View

20.

Matsuzaki H, Hara M, Yanagi Y, Asaumi J, Katase N, Unetsubo T . Magnetic resonance imaging (MRI) and dynamic MRI evaluation of extranodal non-Hodgkin lymphoma in oral and maxillofacial regions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 113(1):126-33. DOI: 10.1016/j.tripleo.2011.07.038. View